CClinicalTrials.gg
Status unknownNCT03469700Updated Sep 27, 2019

General Anesthesia vs Paravertebral Block With General Anesthesia For Laparoscopic Sleeve Gastrectomy

An interventional study of general anesthesia and Paravertebral block in Pain, Postoperative, sponsored by Makassed General Hospital. Status unknown at 1 site in Lebanon. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2019-09-27.

Sponsored by Makassed General Hospital · Not applicable, Interventional, and Other

The sponsor has not verified this record recently (last verified Sep 2019), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

The incidence of obesity is steadily rising. Laparoscopic sleeve gastrectomy (LSG) is an innovative approach to the surgical management of morbid obesity.

We will be discussing the effect of adding paravertebral block (PVB) in addition to general anesthesia (GA) vs. GA alone for post operative pain after laparoscopic sleeve gastrectomy.

Read the detailed description

This is a prospective, randomized, double-blind controlled clinical trial. Written informed consent will be obtained from patients. Patients will be randomly assigned using the sealed envelope technique into 2 equal groups: Group 1 will be patients who receive general anesthesia with paravertebral block, whereas group 2 will be patients who receive general anesthesia with placebo block.

02

Conditions studied

  • Pain, Postoperative

Browse trials for

03

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients with body mass index (BMI) greater than or equal to 30
  • American Society of Anesthesiologist (ASA) score greater than or equal to 2
  • Undergoing laparoscopic gastric sleeve surgeries

Exclusion criteria

Exclusion Criteria:

  • Patients with ASA score less than 2 and greater than 4
  • Patients with any type of allergy to local anesthesia
  • Patients refusing to be part of the study (refusal to sign consent)
  • Any complication during surgery or anesthesia
04

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    GA+PVB

    Patients will receive general anesthesia with paravertebral block

    Other: general anesthesia · Other: Paravertebral block

  • Active comparator
    GA+placebo PVB

    Patients will receive general anesthesia with placebo block

    Other: general anesthesia · Other: Placebo PVB

Interventions

  • Othergeneral anesthesia

    Induction of general anesthesia will be performed followed by endotracheal intubation. General anesthesia is induced with 0.5-1 μg/kg fentanyl, 1.5-2 mg/kg propofol and 1-2 mg midazolam. Then, endotracheal intubation is facilitated by 0.15 mg/kg nimbex. Anesthesia is maintained by 1-1.5% sevoflurane, 0.5 μg/kg/h fentanyl, 0.6 mg/kg/h rocuronium, 60% nitrous oxide and 40% oxygen with Ultiva (Remifentanyl) 0.1-0.2 μg/kg/hr

  • OtherParavertebral block

    Bilateral paravertebral block guided by a nerve stimulator will be performed by injecting local anesthetic mixture from levels T11 to T6. Each 20 ml of the mixture will contain: 6 ml lidocaine 2%; 6 ml lidocaine 2% with adrenaline 5 μg /ml; 5 ml bupivacaine 0.5%; 50μg fentanyl (1 ml); and 2 ml saline 0.9%

  • OtherPlacebo PVB

    Placebo bilateral paravertebral block guided by a nerve stimulator will be performed by injecting normal saline from levels T11 to T6.

05

What researchers measure

Primary outcomes

  1. postoperative pain

    The primary aim is to compare the effect of paravertebral block with general anesthesia versus general anesthesia alone on postoperative pain after laparoscopic sleeve gastrectomy surgeries. Pain will be assessed using the Visual Analogue scale (VAS) with a score of 0 denoting no pain and 10 maximum possible pain.

    Time frame: within 1 week postoperatively

Secondary outcomes

  1. ambulation

    The secondary aim is to assess the time of first movement (early ambulation) between both groups. This will be assessed via a questionnaire

    Time frame: within 1 week postoperatively

06

Study locations

1 of 1 sites recruiting
  • Makassed General Hospital
    Beirut, Lebanon
    Recruiting
07

Registry details

Key details

Study ID
NCT03469700
Lead sponsor
Makassed General Hospital
Responsible party
Saleh Kanawati (Anesthesiologist, Makassed General Hospital) — Principal investigator
First posted
Mar 19, 2018
Start date
Mar 15, 2018
Primary completion
Dec 2019 (estimated)
Completion
Dec 2019 (estimated)
Last update
Sep 27, 2019

Study contacts

Saleh Kanawati, MD
Contact
s.kanawati@hotmail.com
+9611636000 ext. 6405
Saleh Kanawati, MD
principal investigator · Makassed General Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion